GenMont Biotech Incorporation (TPE:3164)
17.40
-0.10 (-0.57%)
May 8, 2026, 1:22 PM CST
-13.65% (1Y)
| Market Cap | 1.50B -5.7% |
| Revenue (ttm) | 390.95M +6.1% |
| Net Income | 44.89M +15.2% |
| EPS | 0.52 +15.7% |
| Shares Out | 86.01M |
| PE Ratio | 33.41 |
| Forward PE | n/a |
| Dividend | 0.80 (4.60%) |
| Ex-Dividend Date | Apr 8, 2026 |
| Volume | 54,407 |
| Average Volume | 50,625 |
| Open | 17.75 |
| Previous Close | 17.50 |
| Day's Range | 17.40 - 17.75 |
| 52-Week Range | 17.20 - 22.40 |
| Beta | 0.12 |
| RSI | 34.28 |
| Earnings Date | May 15, 2026 |